Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response

被引:22
|
作者
Hingane, Smita [1 ]
Joshi, Nishant [1 ,3 ]
Surjit, Milan [1 ]
Ranjith-Kumar, C. T. [1 ,2 ]
机构
[1] Translat Hlth Sci & Technol Inst, Virol Lab, Vaccine & Infect Dis Res Ctr, Gurgaon, India
[2] Guru Gobind Singh Indraprastha Univ, Univ Sch Biotechnol, Dwarka, India
[3] Shiv Nadar Univ, Dept Life Sci, Gautam Buddha Nagar, India
来源
FRONTIERS IN MICROBIOLOGY | 2020年 / 11卷
关键词
HEV; ORF2; RIG-I; interferon; innate immunity; CAPSID PROTEIN; EXPRESSION; RECOGNITION; GLYCOSYLATION; PARTICLES; RECEPTORS; INDUCTION; GENE;
D O I
10.3389/fmicb.2020.00656
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Understanding the dynamics of host innate immune responses against a pathogen marks the first step toward developing intervention strategies against the pathogen. The cytosolic pattern recognition receptor retinoic acid-inducible gene I (RIG-I) has been shown to be the major innate immune sensor for hepatitis E virus (HEV). Here, we show that HEV capsid protein (ORF2), a 660 amino acid long protein, interferes with the RIG-I signaling. Interestingly, only the full length ORF2 protein but not the 112-608 ORF2 protein inhibited RIG-I dependent interferon response. Both synthetic agonist and virus induced RIG-I activation was modulated by ORF2. Interference of interferon response was confirmed by reporter assays involving different interferon inducible promoters, qRT PCR, ELISA, and immunofluorescence microscopy. Neither glycosylation nor dimerization of the ORF2 protein had any effect on the observed inhibition. Further analyses revealed that the ORF2 protein antagonized Toll-like receptor (TLR) pathways as well. ORF2 inhibited signaling by RIG-I and TLR adapters, IPS-1, MyD88, and TRIF but was unable to inhibit activation by ectopically expressed IRF3 suggesting that it may be acting at a site upstream of IRF3 and downstream of adapter proteins. Our data uncover a new mechanism by which HEV may interfere with the host antiviral signaling.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells
    Surjit, Milan
    Varshney, Bhavna
    Lal, Sunil K.
    BMC BIOCHEMISTRY, 2012, 13
  • [22] The ORF2 protein of hepatitis E virus inhibits NFκB activity by exploiting the ER retrotranslocation pathway.
    Surjit, M
    Kumar, R
    Lal, SK
    HEPATOLOGY, 2004, 40 (04) : 286A - 287A
  • [23] Characterization of Hepatitis E Virus Recombinant ORF2 Proteins Expressed by Vaccinia Viruses
    Jimenez de Oya, Nereida
    Escribano-Romero, Estela
    Blazquez, Ana-Belen
    Lorenzo, Maria
    Martin-Acebes, Miguel A.
    Blasco, Rafael
    Saiz, Juan-Carlos
    JOURNAL OF VIROLOGY, 2012, 86 (15) : 7880 - 7886
  • [24] Prediction of promiscuous epitopes in ORF2 of Hepatitis E virus: an In-Silico approach
    Samavia, Noor
    Fahed, Parvaiz
    Yasir, Waheed
    Tasneem, Anwar
    Syeda, Nasreen
    AFRICAN HEALTH SCIENCES, 2022, 22 (03) : 626 - 639
  • [25] Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response
    Tasaka, Megumi
    Sakamoto, Naoya
    Nakagawa, Mina
    Itsui, Yasuhiro
    Sekine-Osajima, Yuko
    Nishimura-Sakurai, Yuki
    Chen, Cheng-Hsin
    Yoneyama, Mitsutoshi
    Fujita, Takashi
    Wakita, Takaji
    Maekawa, Shinya
    Enomoto, Nobuyuki
    Watanabe, Mamoru
    JOURNAL OF GENERAL VIROLOGY, 2007, 88 : 3323 - 3333
  • [26] Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein
    Montpellier, C.
    Wychowski, C.
    Sayed, I. M.
    Meunier, J. -C.
    Saliou, J. -M.
    Ankavay, M.
    Bull, A.
    Pillez, A.
    Abravanel, F.
    Helle, F.
    Brochot, E.
    Drobecq, H.
    Farhat, R.
    Aliouat-Denis, C. -M.
    Haddad, J. G.
    Izopet, J.
    Meuleman, P.
    Goffard, A.
    Dubuisson, J.
    Cocquerel, L.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S781 - S782
  • [27] Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection
    Yin, Xin
    Ying, Dong
    Lhomme, Sebastien
    Tang, Zimin
    Walker, Christopher M.
    Xia, Ningshao
    Zheng, Zizheng
    Feng, Zongdi
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (18) : 4773 - 4778
  • [28] Cloning and expression of truncated ORF2 as a vaccine candidate against hepatitis E virus
    Dibya Rani
    Rahul Saxena
    Baibaswata Nayak
    Sudha Srivastava
    3 Biotech, 2018, 8
  • [29] Monitoring of hepatitis E virus infection and replication by functional tagging of the ORF2 protein
    Ankavay, Maliki
    Da Silva, Nathalie
    Pollan, Angela
    Oechslin, Noemie
    Dinkelborg, Katja
    Behrendt, Patrick
    Moradpour, Darius
    Gouttenoire, Jerome
    JHEP REPORTS, 2025, 7 (03)
  • [30] Cloning and expression of truncated ORF2 as a vaccine candidate against hepatitis E virus
    Rani, Dibya
    Saxena, Rahul
    Nayak, Baibaswata
    Srivastava, Sudha
    3 BIOTECH, 2018, 8 (10)